Search Result "Substantia nigra"


Influence of Aging on the Dopaminergic Neurons in the Substantia Nigra Pars Compacta of Rats

Journal: Current Aging Science
Volume: 4 Issue: 1 Year: 2011 Page: 19-24
Author(s): Jin Gao, Hui Miao, Cheng-hua Xiao, Yu Sun, Xia Du, Hong-hua Yuan, Hong-li Yu, Dian-shuai Gao

Enhanced Hyperthermia Induced by MDMA in Parkin Knockout Mice

Journal: Current Neuropharmacology
Volume: 9 Issue: 1 Year: 2011 Page: 96-99
Author(s): Y. Takamatsu, H. Shiotsuki, S. Kasai, S. Sato, T. Iwamura, N. Hattori, K. Ikeda

Role of Nitric Oxide in Motor Control: Implications for Parkinsons Disease Pathophysiology and Treatment

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 5 Year: 2011 Page: 471-488
Author(s): Elaine Del-Bel, Fernando Eduardo Padovan-Neto, Rita Raisman-Vozari, Marcio Lazzarini

Molecular Manipulation Targeting Regulation of Dopaminergic Differentiation and Proliferation of Neural Stem Cells or Pluripotent Stem Cells

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 4 Year: 2011 Page: 517-525
Author(s): Yin-Xiu Ding, Li-Chun Wei, Ya-Zhou Wang, Rong Cao, Xi Wang, Liang-Wei Chen

Nitric Oxide Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinsons Disease and Other Motor Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 7 Year: 2011 Page: 777-791
Author(s): Massimo Pierucci, Salvatore Galati, Mario Valentino, Vincenzo Di Matteo, Arcangelo Benigno, Alessandro Pitruzzella, Richard Muscat, Giuseppe Di Giovanni

The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinsons disease

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 5 Year: 2011 Page: 489-507
Author(s): Rui D. S. Prediger, Aderbal S. Aguiar, Eduardo L. G. Moreira, Filipe C. Matheus, Adalberto A. Castro, Roger Walz, Andreza F. De Bem, Alexandra Latini, Carla I. Tasca, Marcelo Farina, Rita Raisman-Vozari

Potential Application of Induced Pluripotent Stem Cells in Cell Replacement Therapy for Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 4 Year: 2011 Page: 449-458
Author(s): L. W. Chen, F. Kuang, L. C. Wei, Y. X. Ding, K. K.L. Yung, Y. S. Chan

Histamine H3 Receptor (H3R) Antagonists and Inverse Agonists in the Treatment of Sleep Disorders

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 1 Year: 2011 Page: 1426-1429
Author(s): Meredith Broderick, Tony Masri

Commentary (Research Highlights)

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 1 Year: 2011 Page: 1-1
Author(s): Stephen D. Skaper

Dopamine: The Forgotten Felon in Type 2 Diabetes

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 5 Issue: 1 Year: 2011 Page: 61-65
Author(s): Sanjay Kalra, Bharti Kalra, Navneet Agrawal, Satish Kumar

Previous   Next

Go To   Results 1 - 1 of 172

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy